Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities

Care Transition Clinical Trial

Official title:

Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities Using a Pharmacy Integrated Transitional Team

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05241951
• Other study ID #: STUDY00011018
• Secondary ID: 1R01HS027805
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 31, 2022
• Est. completion date: July 31, 2025

Study information

• Verified date: May 2024
• Source: University of Washington
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The Pharmacy Integrated Transitions (PIT) program, utilizes a crossover randomized control design to evaluate the impact of a clinical pharmacist in decreasing medication related problems during a patient's transition from hospital to skilled nursing facility (SNF).

Description:

Standard hospital discharge processes (e.g. as recommended by the Joint Commission Center for Transforming Healthcare), include hospital staff completing a paper-based discharge summary and medication reconciliation form. To reduce the likelihood of medication-related problems during care transitions, the Pharmacy Integrated Transitions (PIT) program aims to improve the standard transition process by adding a coordinating transitional pharmacist to provide a structured synchronous "warm-handoff" between clinical teams at the hospital and the Skilled Nursing Facility, in addition to reconciling, adjusting, and monitoring medications during and after discharge from the hospital.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 5760
• Est. completion date: July 31, 2025
• Est. primary completion date: July 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age and older

• patients receiving inpatient care at University of Washington Mountlake, University of Washington Northwest, Harborview, and Valley Medical Center hospitals to one of 14 collaborating SNF's on a day when the PIT program pharmacist is conducting the intervention

Exclusion Criteria:

• Under 18 years of age

• patients with a discharge on hospice care

• patients discharged on days that the pharmacist is not conducting the intervention

Related Conditions & MeSH terms

• Care Transition

Intervention

Other:
• Structured hand-off
Use of standardized checklist to provide synchronous or asynchronous handoff that conveys medication recommendations to the SNF clinical teams
• Medication reconciliation during transitional period
Comprehensive medication reconciliation conducted during transitional period between hospital and SNF, focused on SNF-specific requirements for medication delivery (e.g., stop dates, titration instructions)
• Transitional medication monitoring
Review of medication orders during first 7 days of SNF admittance to address barriers to translation of medication orders and appropriate medication delivery
• Teleconsultation
Ad hoc consultation to provide additional clarification to SNF clinical teams

Locations

Country	Name	City	State
United States	University of Washington Health System	Seattle	Washington

Sponsors (2)

Lead Sponsor	Collaborator
University of Washington	Agency for Healthcare Research and Quality (AHRQ)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Medication Related Problems	Number of medication related problems experienced by patients within 30 days post hospital discharge.	30 days post hospital discharge
Secondary	Death	Number of deaths experienced by patients within each cohort	30 Days post hospital discharge
Secondary	Readmissions	Number of readmissions within 30 days of index hospital discharge	30 Days

External Links

•   Focused on evaluating the effectiveness and value of healthcare and keeping the patient's voice central, CERTAIN is a revolutionary approach to improving quality through actionable research.